5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). © 2015 The Cochrane Collaboration.
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2015
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23701
- Acceso en línea:
- https://doi.org/10.1002/14651858.CD011928
https://repository.urosario.edu.co/handle/10336/23701
- Palabra clave:
- Dutasteride
Finasteride
Steroid 5alpha reductase inhibitor
Article
Benign prostatic obstruction
Clinical protocol
Disease association
Disease severity
Drug effect
Human
International prostate symptom score
Lower urinary tract symptom
Outcome assessment
Priority journal
Prostate disease
Quality of life
Systematic review
Urine retention
Urogenital tract disease assessment
- Rights
- License
- Abierto (Texto Completo)